Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ON101 Cream for Venous Leg Ulcers
NCT05322525Phase 4Terminated
- Sponsor
- Oneness Biotech Co., Ltd.
- Start
- Jun 2021
- Primary completion
- Aug 2023
- Modality
- Botanical drug
- Countries
- 1
01
Overview
A Phase 4 trial of Fespixon in venous leg ulcer (VLU), sponsored by Oneness Biotech Co., Ltd.. Started Jun 2021; status: terminated.
02
Drugs
Fespixon
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT05322525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05322525.